Charles River Laboratories International, Inc. Common Stock (CRL)

$167.10 0.00 (0.00%)

19:00 EST CRL Stock Quote Delayed 30 Minutes

CRL Stock Earnings: Charles River Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 9, 2024

CRL stock results show that Charles River beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

The 7 Best Growth Stocks to Buy in May 2024

The Top 3 Healthcare Stocks to Buy in March 2024

The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.

Volume:

Previous Close -

Market Cap 8.42B

PE Ratio 835.50

EPS 0.2

Volume (Avg. Vol.) 327

Day's Range -

52-Week Range $150.79 - $275.00

Dividend & Yield N/A (N/A)

CRL Stock Predictions, Articles, and Charles River Laboratories International, Inc. Common Stock News

The 7 Best Growth Stocks to Buy Now

By Ian Bezek, InvestorPlace Contributor Jan 9, 2024

Growth stocks are picking up steam, and these seven have a great outlook for the rest of the year and beyond.

Investing in the Aging Population: 3 Healthcare Stocks to Watch

By Ian Bezek, InvestorPlace Contributor Dec 7, 2023

America is becoming a much older country on average. These three healthcare stocks are ideally positioned for this demographic shift.

The 3 Most Undervalued Tech Stocks to Buy Now: November 2023

By Ian Bezek, InvestorPlace Contributor Nov 17, 2023

Growth stocks are rallying but there are still bargains to be found. These three top tech picks can reward long-term investors.

Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar

By Ian Bezek, InvestorPlace Contributor Oct 5, 2023

But it's not time to give up on the stock market. In fact, thanks to the recent selling, bargains are springing up across many S&P 500 stocks.

Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.

By Will Ashworth, InvestorPlace Contributor Sep 6, 2023

VinFast stock has gotten inflated since its blank-check merger in early August. Check out these three EV stocks instead.

Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points

By Muslim Farooque, InvestorPlace Contributor Aug 2, 2023

Explore the resilience of healthcare stocks that are demonstrating signs of recovery, with robust long-term growth potential ahead.

3 Cheap Stocks to Buy Before They Bounce Back

By Ian Bezek, InvestorPlace Contributor Jul 4, 2023

Afraid of missing out on the big market rally? These three cheap stocks are still strong buys today.

3 Long-term Healthcare Stocks to Add to Your Portfolio

By Ian Bezek, InvestorPlace Contributor Jun 14, 2023

These long-term healthcare stocks should benefit from the global surge in spending for life-improving pharmaceutical drugs, therapies, and medical devices.

3 DNA Stocks to Buy for the Synthetic Biology Revolution

By John Blankenhorn, InvestorPlace Contributor May 14, 2023

Synthetic biology is a growing industry. The big winners will be DNA stocks that are able to sell to everyone, not just a small niche.

3 Healthcare Stocks With Huge Growth Potential

By Ian Bezek, InvestorPlace Contributor Apr 24, 2023

It's been a tough time for the tech industry. So consider these healthcare growth stocks to buy now instead.

Commanding Earnings Momentum Metrics Raise Ranking of Charles River Labs (CRL) to Strong Buy

By Portfolio Grader Nov 9, 2017

Charles River Labs (NYSE:CRL) is ranked as a Strong Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. CRL has been upgraded from a Buy to a Strong Buy in the last week.

Charles River Laboratories Intl. Inc Can Keep the Run Going

By Hilary Kramer, Editor, GameChangers Oct 23, 2017

The 50%-plus gains in Charles River Laboratories year-to-date might scare off some investors, but CRL stock still looks to have upside.

5 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Dec 1, 2016

The ratings of 5 Life Sciences Tools & Services stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

6 Life Sciences Tools & Services Stocks to Sell Now

By Portfolio Grader Nov 10, 2016

This week, the ratings of 6 Life Sciences Tools & Services stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

4 Life Sciences Tools & Services Stocks to Buy Now

By Portfolio Grader Oct 6, 2016

The grades of 4 Life Sciences Tools & Services stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").

4 Life Sciences Tools & Services Stocks to Buy Now

By Portfolio Grader May 12, 2016

4 Life Sciences Tools & Services stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").